Schedule 13D ownership disclosure
Anixa Biosciences Inc
Common Stock · CUSIP: 03528H109
Event date: 2025-01-02
- Filing-level shares
- 5,653,343.00
- Percent of class
- 15.1%
- Amit KumarReported CIK 0001191905
Shares: 5,653,343.00 · Class: 15.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-000323
- Form type
- SCHEDULE 13D/A
- Filer
- Anixa Biosciences Inc
- CIK
- CIK 715446
- Filed
- Jan 03, 2025
- Reporting period
- Jan 02, 2025
- Description
- Schedule 13D beneficial ownership